FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3149285877> ?p ?o ?g. }

• W3149285877 endingPage "714" @default.
• W3149285877 startingPage "714" @default.
• W3149285877 abstract "Persistent paranoia is common among patients with psychosis. Cognitive-behavioral therapy for psychosis can be effective. However, challenges in engagement and effectiveness remain.To investigate the effects on paranoia and mechanisms of action of SlowMo, a digitally supported reasoning intervention, plus usual care compared with usual care only.This parallel-arm, assessor-blinded, randomized clinical trial recruited participants at UK community health services from May 1, 2017, to May 14, 2019. Eligible participants consisted of a referral sample with schizophrenia-spectrum psychosis and distressing, persistent (≥3 months) paranoia.Individuals were randomized 1:1 to SlowMo, consisting of 8 digitally supported face-to-face sessions and a mobile app, plus usual care (n = 181) and usual care only (n = 181).The primary outcome was paranoia, measured by the Green et al Paranoid Thoughts Scale (GPTS) total score at 24 weeks. Secondary outcomes included GPTS total score at 12 weeks and GPTS Part A (reference) and Part B (persecutory) scores, the Psychotic Symptom Rating Scales (PSYRATS Delusion subscale), reasoning (belief flexibility, possibility of being mistaken [Maudsley Assessment of Delusions, rated 0%-100%]), and jumping to conclusions (Beads Task).A total of 361 participants were included in intention-to-treat analysis, of whom 252 (69.8%) were male and 249 (69.0%) were White; the mean (SD) age was 42.6 (11.6) years. At 24 weeks, 332 participants (92.0%) provided primary outcome data. Of 181 participants in the SlowMo group, 145 (80.1%) completed therapy. SlowMo plus usual care was not associated with greater reductions than usual care in GPTS total score at 24 weeks (Cohen d, 0.20; 95% CI, -0.02 to 0.40; P = .06). There were significant effects on secondary paranoia outcomes at 12 weeks, including GPTS total score (Cohen d, 0.30; 95% CI, 0.09-0.51; P = .005), Part A score (Cohen d, 0.22; 95% CI, 0.06-0.39; P = .009), and Part B score (Cohen d, 0.32; 95% CI, 0.08-0.56; P = .009), and at 24 weeks, including Part B score (Cohen d, 0.25; 95% CI, 0.01-0.49; P = .04) but not Part A score (Cohen d, 0.12; 95% CI, -0.05 to 0.28; P = .18). Improvements were observed in an observer-rated measure of persecutory delusions (PSYRATS delusion) at 12 weeks (Cohen d, 0.47; 95% CI, 0.17-0.78; P = .002) and 24 weeks (Cohen d, 0.50; 95% CI, 0.20-0.80; P = .001) and belief flexibility at 12 weeks (Cohen d, 0.29; 95% CI, 0.09-0.49; P = .004) and 24 weeks (Cohen d, 0.28; 95% CI, 0.08-0.49; P = .005). There were no significant effects on jumping to conclusions. Improved belief flexibility and worry mediated paranoia change (range mediated, 36%-56%).SlowMo did not demonstrate significant improvements in the primary measure of paranoia at 24 weeks; however, a beneficial effect of SlowMo on paranoia was indicated by the results on the primary measure at an earlier point and on observer-rated paranoia and self-reported persecution at 12 and 24 weeks. Further work to optimize SlowMo's effects is warranted.isrctn.org Identifier: ISRCTN 32448671." @default.
• W3149285877 created "2021-04-13" @default.
• W3149285877 creator A5025771919 @default.
• W3149285877 creator A5029652042 @default.
• W3149285877 creator A5036498218 @default.
• W3149285877 creator A5037465911 @default.
• W3149285877 creator A5046447698 @default.
• W3149285877 creator A5053708270 @default.
• W3149285877 creator A5056431993 @default.
• W3149285877 creator A5056740773 @default.
• W3149285877 creator A5059135549 @default.
• W3149285877 creator A5065890305 @default.
• W3149285877 creator A5067547893 @default.
• W3149285877 creator A5075856284 @default.
• W3149285877 creator A5078494431 @default.
• W3149285877 creator A5084618181 @default.
• W3149285877 date "2021-07-01" @default.
• W3149285877 modified "2023-10-16" @default.
• W3149285877 title "Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis" @default.
• W3149285877 cites W1609135795 @default.
• W3149285877 cites W1974291831 @default.
• W3149285877 cites W1981059248 @default.
• W3149285877 cites W1986753969 @default.
• W3149285877 cites W2001866454 @default.
• W3149285877 cites W2020616753 @default.
• W3149285877 cites W2055381672 @default.
• W3149285877 cites W2063481387 @default.
• W3149285877 cites W2075412689 @default.
• W3149285877 cites W2082235434 @default.
• W3149285877 cites W2085488608 @default.
• W3149285877 cites W2091606641 @default.
• W3149285877 cites W2096304110 @default.
• W3149285877 cites W2096987981 @default.
• W3149285877 cites W2100376975 @default.
• W3149285877 cites W2102971553 @default.
• W3149285877 cites W2123552131 @default.
• W3149285877 cites W2131204413 @default.
• W3149285877 cites W2135509506 @default.
• W3149285877 cites W2141895509 @default.
• W3149285877 cites W2144585543 @default.
• W3149285877 cites W2151220931 @default.
• W3149285877 cites W2160166915 @default.
• W3149285877 cites W2160332635 @default.
• W3149285877 cites W2163505421 @default.
• W3149285877 cites W2756322225 @default.
• W3149285877 cites W2767101694 @default.
• W3149285877 cites W2772874515 @default.
• W3149285877 cites W2787925782 @default.
• W3149285877 cites W2803173466 @default.
• W3149285877 cites W2808783108 @default.
• W3149285877 cites W2884440658 @default.
• W3149285877 cites W2885804443 @default.
• W3149285877 cites W2890749013 @default.
• W3149285877 cites W2895179039 @default.
• W3149285877 cites W2969972095 @default.
• W3149285877 cites W3013046670 @default.
• W3149285877 cites W4213178377 @default.
• W3149285877 cites W4253528673 @default.
• W3149285877 doi "https://doi.org/10.1001/jamapsychiatry.2021.0326" @default.
• W3149285877 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8027943" @default.
• W3149285877 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33825827" @default.
• W3149285877 hasPublicationYear "2021" @default.
• W3149285877 type Work @default.
• W3149285877 sameAs 3149285877 @default.
• W3149285877 citedByCount "36" @default.
• W3149285877 countsByYear W31492858772021 @default.
• W3149285877 countsByYear W31492858772022 @default.
• W3149285877 countsByYear W31492858772023 @default.
• W3149285877 crossrefType "journal-article" @default.
• W3149285877 hasAuthorship W3149285877A5025771919 @default.
• W3149285877 hasAuthorship W3149285877A5029652042 @default.
• W3149285877 hasAuthorship W3149285877A5036498218 @default.
• W3149285877 hasAuthorship W3149285877A5037465911 @default.
• W3149285877 hasAuthorship W3149285877A5046447698 @default.
• W3149285877 hasAuthorship W3149285877A5053708270 @default.
• W3149285877 hasAuthorship W3149285877A5056431993 @default.
• W3149285877 hasAuthorship W3149285877A5056740773 @default.
• W3149285877 hasAuthorship W3149285877A5059135549 @default.
• W3149285877 hasAuthorship W3149285877A5065890305 @default.
• W3149285877 hasAuthorship W3149285877A5067547893 @default.
• W3149285877 hasAuthorship W3149285877A5075856284 @default.
• W3149285877 hasAuthorship W3149285877A5078494431 @default.
• W3149285877 hasAuthorship W3149285877A5084618181 @default.
• W3149285877 hasBestOaLocation W31492858771 @default.
• W3149285877 hasConcept C118552586 @default.
• W3149285877 hasConcept C126322002 @default.
• W3149285877 hasConcept C138496976 @default.
• W3149285877 hasConcept C15744967 @default.
• W3149285877 hasConcept C168563851 @default.
• W3149285877 hasConcept C2776412080 @default.
• W3149285877 hasConcept C2779043874 @default.
• W3149285877 hasConcept C2779727114 @default.
• W3149285877 hasConcept C2781105514 @default.
• W3149285877 hasConcept C70410870 @default.
• W3149285877 hasConcept C71924100 @default.
• W3149285877 hasConcept C83849319 @default.
• W3149285877 hasConceptScore W3149285877C118552586 @default.
• W3149285877 hasConceptScore W3149285877C126322002 @default.

• next